Implantica AG (publ), announces that the RefluxStop procedure to treat acid reflux is now being successfully implemented at Spire Manchester Hospital, part of the Spire Healthcare Group, with a network of 39 hospitals and 8 clinics across England, Wales and Scotland.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.8 SEK | -0.52% | -3.68% | +20.50% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.50% | 751M | |
+72.39% | 12.33B | |
-18.22% | 7.86B | |
+16.84% | 7.11B | |
+3.48% | 5.77B | |
+8.16% | 5.1B | |
+19.97% | 4.29B | |
-20.59% | 3.92B | |
-42.79% | 2.2B | |
+0.87% | 1.92B |
- Stock Market
- Equities
- IMP A SDB Stock
- News Implantica AG
- Implantica Announces Spire Manchester Hospital in UK Begins Operating with RefluxStop™